Autor(es): Cardoso, Isabel ; Nunes, Sofia ; Brás, Pedro ; Viegas, José Miguel ; Marques Antunes, Miguel ; Ferreira, André ; Almeida, Inês ; Custódio, Inês ; Trigo, Conceição ; Laranjo, Sergio ; Graça, Rafael ; Ferreira, Rui Cruz ; Oliveira, Mario ; Aguiar Rosa, Sílvia ; Antunes, Diana
Data: 2025
Identificador Persistente: http://hdl.handle.net/10400.5/100149
Origem: Repositório da Universidade de Lisboa
Assunto(s): Cardiomyopathies; Genetics; Genotype; Next-generation sequencing
Genetics has assumed a pivotal role in clarifying the pathophysiology of cardiomyopathies, facilitating molecular diagnosis, and enabling effective family screening. The advent of next-generation sequencing has revolutionized genetic testing by enabling cost-effective, high-throughput analysis. It is imperative for cardiovascular physicians to mainstream genetic testing into their clinical decision-making. Although a definitive genotype-phenotype correlation may not always be evident, several genotypes have emerged as valuable risk predictors for disease severity and progression. European guidelines emphasize the importance of genetic tests for predicting clinical outcome in cardiomyopathies. While further research is essential to bridge existing gaps in the genetic evidence on cardiomyopathies, there is considerable potential for significant advancements.
